ChemoCentryx Statistics Share Statistics ChemoCentryx has 0
shares outstanding. The number of shares has increased by 2.07%
in one year.
Shares Outstanding n/a Shares Change (YoY) 2.07% Shares Change (QoQ) 1.66% Owned by Institutions (%) n/a Shares Floating 58.98M Failed to Deliver (FTD) Shares n/a FTD / Avg. Volume n/a
Short Selling Information The latest short interest is 7.64M, so 0% of the outstanding
shares have been sold short.
Short Interest 7.64M Short % of Shares Out n/a Short % of Float 11.33% Short Ratio (days to cover) 9.38
Valuation Ratios The PE ratio is -18.53 and the forward
PE ratio is null.
ChemoCentryx's PEG ratio is
-0.14.
PE Ratio -18.53 Forward PE n/a PS Ratio 74.22 Forward PS n/a PB Ratio 8.36 P/FCF Ratio -25.27 PEG Ratio -0.14
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for ChemoCentryx.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 4.27,
with a Debt / Equity ratio of 0.02.
Current Ratio 4.27 Quick Ratio 4.26 Debt / Equity 0.02 Debt / EBITDA -0.04 Debt / FCF -0.05 Interest Coverage 49.89
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $181.03K Profits Per Employee $-725.06K Employee Count 178 Asset Turnover 0.08 Inventory Turnover 0.35
Taxes Income Tax -2.69M Effective Tax Rate 2.05%
Stock Price Statistics The stock price has increased by 0% in the
last 52 weeks. The beta is 1.23, so ChemoCentryx's
price volatility has been higher than the market average.
Beta 1.23 52-Week Price Change n/a 50-Day Moving Average 51.46 200-Day Moving Average 31.96 Relative Strength Index (RSI) 79.01 Average Volume (20 Days) 2,020,634
Income Statement In the last 12 months, ChemoCentryx had revenue of 32.22M
and earned -129.06M
in profits. Earnings per share was -1.96.
Revenue 32.22M Gross Profit 31.92M Operating Income -134.45M Net Income -129.06M EBITDA -131.31M EBIT -134.45M Earnings Per Share (EPS) -1.96
Full Income Statement Balance Sheet The company has 49.98M in cash and 4.71M in
debt, giving a net cash position of 45.26M.
Cash & Cash Equivalents 49.98M Total Debt 4.71M Net Cash 45.26M Retained Earnings -617.1M Total Assets n/a Working Capital n/a
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -75.62M
and capital expenditures -19.02M, giving a free cash flow of -94.64M.
Operating Cash Flow -75.62M Capital Expenditures -19.02M Free Cash Flow -94.64M FCF Per Share -1.44
Full Cash Flow Statement Margins Gross margin is 99.06%, with operating and profit margins of -417.24% and -400.51%.
Gross Margin 99.06% Operating Margin -417.24% Pretax Margin -408.87% Profit Margin -400.51% EBITDA Margin -407.49% EBIT Margin -417.24% FCF Margin -293.7%
